Literature DB >> 2743716

Treatment of Behçet's disease with dapsone.

M Hamza, K Hamzaoui, K Ayed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2743716     DOI： 10.1007/bf02031080

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  4 in total

1.  Thalidomide and cell mediated immunity in Behçet's disease.

Authors:  M Hamza; K Hamzaoui; K Ayed; M Eleuch; A Zribi
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

2.  Suppression of Behçet's disease with dapsone.

Authors:  K E Sharquie
Journal:  Br J Dermatol       Date:  1984-04       Impact factor: 9.302

3.  Effectiveness of dapsone in Behcet's disease.

Authors:  J Convit; M Goihman-Yahr; A J Rondón-Lugo
Journal:  Br J Dermatol       Date:  1984-11       Impact factor: 9.302

4.  Treatment of Behçet's disease with thalidomide.

Authors:  M H Hamza
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980
  4 in total
  1 in total

1.  A rare manifestation of Behçet's syndrome: immunological correlates and successful treatment of an esophageal ulcer.

Authors:  Heiner Wedemeyer; Jens G Kuipers; Konrad Streetz; Michael Mengel; Ingolf Schedel; Nikolina Kezmic; Peter Meier; Henning Zeidler; Michael P Manns; Siegfried Wagner
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.